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Background: Aging is associated with physiological or pathological left ventricular hypertrophy (LVH) cardiac
changes. Secondhand smoke (SHS) exposure is associated with pathological LVH. The action mechanism in cardiac
concentric hypertrophy from SHS exposure is understood, but the transition contributed from SHS exposure is not.
To determine whether exposure to SHS has an impact on age-induced LVH we examined young and old hamsters
that underwent SHS exposure in a chamber for 30 mins.
Methods: Morphological and histological studies were then conducted using hematoxylin and eosin (H&E) and
Masson’s trichrome staining. Echocardiographic analysis was used to determine left ventricular wall thickness and
function. LVH related protein expression levels were detected by western blot analysis.
Results: The results showed that both young and aged hamsters exposed to SHS exhibited increased heart
weights and left ventricular weights, left ventricular posterior wall thickness and intraventricular septum systolic
and diastolic pressure also increased. However, left ventricular function systolic and diastolic pressure deteriorated.
H&E and Masson’s trichrome staining results showed LV papillary muscles were ruptured, resulting in lower cardiac
function at the myocardial level. LV muscle fiber arrangement was disordered and collagen accumulation occurred.
Concentric LVH related protein molecular markers increased only in young hamsters exposed to SHS. However, this
declined with hamster age. By contrast, eccentric LVH related proteins increased in aging hamsters exposed the
SHS. Pro-inflammatory proteins, IL-6, TNF-α, JAK1, STAT3, and SIRTI expression increased in aging hamsters exposed
to SHS.
Conclusions: We suggest that SHS exposure induces a pro-inflammatory response that results in concentric
transition to aging eccentric LVH.
Keywords: Left ventricular hypertrophy, Secondhand smoke exposure, Aging, Pro-inflammatory response,
Aged SHS exposureBackground
Secondhand smoke (SHS) exposure is a well known con-
tributor to cardiovascular disease among non-smokers
[1,2]. Little known about how SHS exposure affects
aging changes. The molecular mechanisms of cardiac
aging exposed to SHS are still unclear, especially, the
transition from concentric to eccentric left ventricular
hypertrophy. This study attempts to determine whether* Correspondence: cyhuang@mail.cmu.edu.tw
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unless otherwise stated.SHS exposure leads the transition from concentric to
eccentric left ventricular hypertrophy (LVH) using mo-
lecular signaling pathway regulation markers. SHS geno-
toxicity leading to cardiovascular diseases resulting in
human pathological cardiac hypertrophy has been con-
firmed [3,4]. Previous studies elucidated that cigarette
SHS exposure among children [5,6] might cause irre-
versible impairment in endothelium-dependent vasodila-
tion, but the impact in old age is still unclear. The aging
heart undergoes slowly progressive structural changes
and functional decline with age [7,8]. A number of
pathological mechanisms may arise from the deleterious
effects of SHS exposure [6]. The physiologic changes inis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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creased cardiac fibrosis and valvular degeneration [9,10].
Aging changes in the elderly heart are associated with
physiological and pathological LV hypertrophy. Aging
heart changes can produce cardiac diseases, including cor-
onary arteries [11], myocardial infarction, cardiac valves,
aortic regurgitation [12,13]. Without a doubt, LV hyper-
trophy is related to changes in cardiac morphology includ-
ing increased myocyte size [14], increased left ventricular
wall thickness and decreased fiber density [15,16]. Once
the aging heart experiences extended elevated workload,
the left ventricle becomes deficient in pumping adequate
blood. Thus, pathological aging related LV hypertrophy
[17] may be associated with cardiovascular disease [18].
The physiological aging associated changes [19] in the
heart cannot be reversed and deteriorate in function. The
transition between LV concentric hypertrophy and LV
eccentric hypertrophy is our interest.
Methods
Animals
We purchased male hamsters at ages 6 weeks and
72 weeks from the National Science Council Animal
Center. The animals were group-housed six per cage in
an animal room. The experimental protocols were
conducted in accordance with committee approved
animal care and experimental guidelines from the
Taiwan Society for Laboratory Animals Sciences. Male
hamsters were used in these studies. Only male ham-
sters are used to reduce the potential for variability
from gender-related differences in cardiac aging. All
the animal handling protocols were reviewed and
approved by the Institutional Review Board (IRB),
Animal care and use committee of the China Medical
University, Taichung, Taiwan (ROC).
Experimental design and secondhand smoke (SHS)
exposures
Young and aged groups were divided into two subgroups
for secondhand smoke (SHS) exposure. (1) control; ham-
sters were not exposed to secondhand cigarette smoke.
(2) SHS exposure; hamsters exposed to cigarette second-
hand smoke. The four groups of hamsters were sub-
jected to experiments as follows: MYC; male young
control, MYS; male young SHS exposure, MOC; male
old control, MOS; male old SHS exposure. Hamsters
were placed in an exposure chamber and then exposed
to 10 cigarettes for 30 min, 4 weeks [19].
Hematoxylin-eosin and Masson’s trichrome staining
To assess the left ventricle cross-sectional area and
extracellular space, the cross sections were stained with
hematoxylin and eosin and incubated for 5 min. Part of
the left ventricular cross section was stained with Masson’strichrome to detect collagen accumulation. The stained
sections were then rinsed with PBS and air dried before
mounting. After gently rinsing with water, the slides were
dehydrated through a graded alcohol series for 15 min,
cleaned in xylene and then covered with a slip.
Left ventricular tissue collection and extraction
After the animal was sacrificed, the atrium and right ven-
tricle were removed. The left ventricle was rinsed in nor-
mal saline and then weighed for left ventricular mass. Left
ventricular tissue extracts were obtained at a concentra-
tion of 0.1 g tissue/mL PBS by homogenizing. The homog-
enates were then placed and centrifuged at 12,000 rpm for
30 mins.
Immunohistochemistry analysis
The left ventricular samples from young and old ham-
sters were fixed and embedded in paraffin. Ten microm-
eter thick tissue sections were cut and then dewaxed
and rehydrated. Slides were blocked in 0.1% bovine
serum albumin with PBS buffer for 30 mins at room
temperature and incubated with mouse SIRT1 monoclo-
nal antibody in PBS for 2 hrs. After washing, sections
were incubated for 30 mins with secondary antibody.
After 5 mins washing, peroxidase was developed using
diaminobenzidine chromogen (DAB) diluted in H2O2
buffer.
Echocardiography
Hamsters were anesthetized with an intraperitoneal
ketamine-xylazine-atropine mixture. We used a com-
mercially available echocardiography system equipped
with a 14 MHz liner transducer. Transthoracic echocar-
diography was performed on young control, old control
and 2 or 4 weeks SHS exposure treated in young and
old hamsters, using a HDI-5000 ultrasound machine
[20]. The following parameters were measured and
calculated using the M-mode image: left ventricular pos-
terior at diastolic (LVPWd) and systolic (LVPWs) wall
thickness, intraventricular septal at diastolic (IVSd) and
systolic (IVSs), fractional shortening (FS%) and ejection
fractional (EF%). All data were transferred online to
computer for subsequent analysis.
Western blotting analysis
Left ventricular samples (1 ug) were homogenized for
5 min and centrifuged at 8,000 g for 20 min. Proteins
were electrophoresed by 10% polyacrylamide gels at
110 V for 90 min, and then transferred to PVDF paper
at 100 mA for 2.5 hr. Incubated PVDF members in 1%
BSA blocking buffer for 1 hr at room temperature. Poly-
clonal antibodies, ANP, BNP, p-MEK1, MEK1, p-ERK1/2,
ERK1/2, GATA4, IL-6, TNF α, JAK1, STAT3, Calcineurin,
p-NFAT, NFAT, p-MEK5, MEK5, p-ERK5 and ERK5 were
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were washed three times in 5 ml and then incubated in
the second antibody solution containing anti-rabbit, or
anti-goat, or anti-mouse IgG horseradish peroxidase for
1 hr. Color development was presented in ECL.
Statistical analysis
All data were assessed as the mean ± SD. The experi-
mental results two-way ANOVA analysis was used to
assess male young control (MYC), male young SHS ex-
posure (MYS), male old control (MOC), and male old
SHS exposure (MOS) groups. *p < 0.05, **p < 0.01, sig-
nificant difference compared with male young control
(MYC). #p < 0.05, ##p < 0.01, significant difference com-
pared with male old control (MOC).
Results
Heart and left ventricular characteristics
Table 1 presents the heart and left ventricular (LV) char-
acteristics of male young control (MYC), male young
SHS exposure (MYS), male old control (MOC) and male
old SHS exposure (MOS) hamsters. Hamsters were
placed in an exposure chamber and exposed to ciga-
rettes daily for 4 weeks. We obtained four groups of
heart and left ventricular (LV) morphology characteris-
tics. The whole body weight in the MYS group was
increased, whereas body weight was decreased in the
MOC group compared with the MYC group. The whole
heart (HW) weights in MYC, MYS, MOC and MOS
groups were 0.46 ± 0.01, 0.52 ± 0.01 (p < 0.05), 0.60 ± 0.03
(p < 0.01) and 0.63 ± 0.03 g (p < 0.01), respectively, when
compared with the MYC group. The left ventricular
(LV) weights in MYC, MYS, MOC and MOS groups
were 0.31 ± 0.01, 0.39 ± 0.01 (p < 0.05), 0.42 ± 0.03 (p <
0.01) and 0.53 ± 0.03 g (p < 0.01), compared with the
MYC group. HW and LV weight in old and old SHS ex-
posure were 0.53 ± 0.01 and 0.63 ± 0.03 g, respectively,Table 1 Morphology of the left ventricle in male young contr
control (MOC) and male old SHS exposure (MOS) hamsters
Young
MYC MY
Animal number (N) 6 6
BW (g) 132.54 ± 4.61 145.67 ±
HW (g) 0.46 ± 0.01 0.52 ±
LV (g) 0.31 ± 0.01 0.39 ±
HW/BW (mg/g) 3.59 ± 0.10 3.88 ±
LV/BW (mg/g) 2.44 ± 0.05 2.67 ±
HW/tibia (mg/mm) 16.21 ± 0.23 19.14 ±
LV/tibia (mg/mm) 11.12 ± 0.25 13.66 ±
Values of represent as mean ± SEM. BW, body weight; HW, whole heart weight; LV,
ventricular weight to body weight; HW/tibia, ratio of whole heart weight to tibia len
significant difference vs MYC. ♦p < 0.05, ♦♦p < 0.01 siginificant difference vs MYS. #pwhen compared with the old group. The results from a
two-way ANOVA suggested that the MYS, MOC and
MOS groups tended toward hypertrophy (Table 1). The
HW/BW ratio in MYC, MYS, MOC and MOS groups
were 3.59 ± 0.10, 3.88 ± 0.07, 4.45 ± 0.15 (p < 0.01) and
5.85 ± 0.38 mg/g (p < 0.01), respectively, compared with
the MYC group, and no significant difference was ob-
served between MYS and MYC group. That is because
of increased body weight in the young adult SHS expos-
ure. Therefore, we could not find HW/BW and LV/BW
ratios changes in the MYS group. However, we also ob-
served the HW/BW and LV/BW ratios in aged SHS ex-
posure groups were higher than those in the old control.
That is because of decreased body weight observed in
the aged SHS exposure group, compared to the other
groups. This may be because of aging or toxic smoke ef-
fect. Interestingly, we examined the HW/tibial and LV/
tibial ratios, we found the HW/tibial and LV/tibial ratios
in MYS, MOC and MOS groups all increased. The HW/
tibial ratio in MYS, MOC and MOS groups were
19.14 ± 0.36 (p < 0.05), 19.84 ± 0.36 (p < 0.01), 24.30 ±
0.70 (p < 0.01) mg/mm, respectively, when compared to
the MYC group. The LV/tibial and HW/tibial ratios have
the same increased and trend left ventricular hypertrophy.
The SHS exposure effect on cardiac function in young
and old hamsters
To identify whether the combination of SHS exposure
and aging effects represent an adaptation of the heart or
an indication of left ventricular dysfunction has been a
matter of controversy. On the one hand, echocardiog-
raphy is imaging method in the assessment of cardiac
(Tables 2 and 3). Summarizes the echocardiographic
characteristics in all groups. LVH was present in MYS,
MOC and MOS hamsters groups. No significant differ-
ences at baseline systolic and diastolic in all young




3.42* 130.26 ± 6.04 127.59 ± 3.52*♦#
0.01* 0.60 ± 0.03**♦ 0.63 ± 0.03**♦♦#
0.01 0.42 ± 0.01**♦ 0.53 ± 0.01**♦♦#
0.07 4.45 ± 0.15**♦ 5.85 ± 0.38**♦♦#
0.11 3.27 ± 0.05**♦ 4.01 ± 0.20**♦♦#
0.36 19.84 ± 0.36**♦ 24.30 ± 0.70**♦♦#
0.47 14.73 ± 0.20**♦ 18.48 ± 0.48**♦♦#
left ventricle; HW/BW, ratio of whole heart weight; LV/BW, ratio of left
gth; LV/tibia, ratio of left ventricular to tibia length. *p < 0.05, **p < 0.01
< 0.05, ##p < 0.01 significant difference from MOC.
Table 2 Changes characteristic of left ventricle in male
young control (MYC), male young SHS exposure (MYS),
male old control (MOC) and male old SHS exposure
(MOS) hamsters
Unit MYC MYS MOC MOS
Animals 6 6 6 6
LVPWd (baseline) mm 0.9 ± 0.2 0.9 ± 0.2 1.0 ± 0.1 1.0 ± 0.4
LVPWd (2 weeks) mm 1.2 ± 0.1 1.9 ± 0.1* 1.9 ± 0.1* 2.0 ± 0.3*#
LVPWd (4 weeks) mm 1.5 ± 0.2 2.0 ± 0.7* 2.0 ± 0.1* 2.0 ± 0.2*
LVPWs (baseline) mm 1.7 ± 0.1 1.7 ± 0.7 1.7 ± 0.1 1.9 ± 0.3*
LVPWs (2 weeks) mm 1.7 ± 0.1 1.7 ± 0.3 2.0 ± 0.2* 2.0 ± 0.2*
LVPWs (4 weeks) mm 1.7 ± 0.1 2.0 ± 0.1* 2.0 ± 0.1* 2.0 ± 0.3*
IVSd (baseline) mm 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.1 ± 0.1
IVSd (2 weeks) mm 1.3 ± 0.1 1.3 ± 0.1 1.3 ± 0.1 1.5 ± 0.3*#
IVSd (4 weeks) mm 1.5 ± 0.1 2.0 ± 0.3* 2.0 ± 0.2* 2.0 ± 0.3*
IVSs (baseline) mm 1.3 ± 0.1 1.4 ± 0.2 1.7 ± 0.3* 1.6 ± 0.2*
IVSs (2 weeks) mm 1.5 ± 0.2 1.9 ± 0.1* 1.9 ± 0.1* 2.0 ± 0.1*#
IVSs (4 weeks) mm 1.6 ± 0.2 2.1 ± 0.2* 2.0 ± 0.1* 2.1 ± 0.1*
Values are mean ± S.E. LVPWd, left ventricular posterior wall thickness at
diastole; LVPWs, left ventricular posterior wall thickness at systolic; IVSd,
Interventricular septum at diastolic; IVSs, Interventricular septum at systolic.
*p < 0.05, **p < 0.01 siginificant difference vs MYC. #p < 0.05, ##p < 0.01
significant differentce from MOC.
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septal (IVSd) at baseline diastolic in all aging groups
were found. Surprisingly, we observed left ventricular
posterior wall thickness (LVPWs) and intraventricular
septal (IVSs) at baseline systemic were increased in aging
and aging without SHS exposure hamsters groups. Be-
cause that aging leads to left ventricular posterior wall
thickness at baseline systolic increased and intraventric-
ular septal dysfunction is enhanced. We first discussed
short-term 2 weeks SHS exposure, we found LVPWd
and IVSs in MYS, MOC and MOS groups were all in-
creased (all p < 0.05) when compared with MOS group,
whereas LVPWs increased in MOC and MOS groups
(p < 0.05), and IVSd was increased in MOS group (p <
0.05). However, when compared with the aging (MOC
group), we observed LVPWd from 1.9 ± 0.1 increased toTable 3 Left ventricular function
Young
Unit MYC
EF (baseline) % 82.05 ± 5.48
EF (2 weeks) % 83.63 ± 1.20
EF (4 weeks) % 79.33 ± 1.84
FS (baseline) % 45.99 ± 5.46
FS (2 weeks) % 45.28 ± 2.28
FS (4 weeks) % 41.28 ± 2.48
Values are mean ± S.E. FS, fractional shortening, EF, ejection fractional. *p < 0.05, **p
differentce from MOC.2.0 ± 0.3 (p < 0.05), IVSd from 1.3 ± 0.1 increased to
1.5 ± 0.3 (p < 0.05), IVSs from 1.9 ± 0.1 increased to
2.0 ± 0.1 (p < 0.05). LVPWs exhibited no significant dif-
ferences in aged exposure to SHS. Furthermore, long-
term 4 weeks exposure to SHS exposure, we found
LVPWd, LVPWs, IVSd and IVSs in MYS, MOC and
MOS groups were all increased when compared with the
MYC group (all p < 0.05). Interestingly, no significant
difference in MOS group was found, when compared
with the MOC group. It is possible with aging. There
were no significant differences between aging and aged
SHS exposure. However, Fraction Shortening (FS%)
and Ejection Fraction (EF%) were progressive impair-
ment in MYC, MYS, MOC and MOS groups at 2 weeks
and 4 weeks SHS exposure (Table 3). LV function de-
clines were observed. In fact, as Table 3 Shows, the
systolic function of left ventricle in MOC and MOS
groups at baseline trended toward lower EF% and FS%
(p < 0.05). These data are strongly indicative of the
elder hamster’s left ventricular dysfunction. Two or
4 weeks SHS exposure, LV function of EF (%) and FS
(%) reduced in young and old hamsters. Indeed, the
aging hamsters exposure to SHS were significantly
lower than old hamsters (p < 0.01).
Changes in left ventricular architecture in male young
control, male young SHS exposure, male old control and
male old SHS exposure hamsters
Hamsters showed tissue architectures and histopatho-
logic of LV hypertrophy in MYC, MYS, MOC and MOS
groups on hematoxylin-eosin staining (H&E) (Figure 1A)
and LV fibrosis by Masson’s trichrome staining (Figure 1B).
According to the results, we found LV papillary muscle
rupture, LV chamber narrow, LV papillary muscle space
increases and observed LV muscle fibers dissociation, ar-
rangement disarray, relaxation, and interstitial spaces
broad in MYS, MOC and MOS groups using H&E
staining (Figure 1A and B). Histological examination
also revealed the extent of LVH. Morphometric sam-
ples are at x100 magnification (Figure 1A, up-panel)
and x400 magnification (Figure 1A, down-panel). InOld
MYS MOC MOS
72.91 ± 3.47 67.88 ± 8.03* 66.47 ± 6.26*
67.33 ± 7.75* 62.12 ± 2.82* 58.33 ± 2.67**#
66.33 ± 3.18* 62.30 ± 2.66* 40.14 ± 8.57**#
40.51 ± 2.85 33.15 ± 5.50* 31.49 ± 4.71*
32.33 ± 5.24* 31.90 ± 1.64* 27.33 ± 1.67**#
32.05 ± 2.52* 27.75 ± 2.27* 17.67 ± 4.67**#
< 0.01 significant difference vs MYC. #p < 0.05, ##p < 0.01 siginificant
Figure 1 Representative histological cross sections of the left ventricle (LV) stained with hematoxylin-eosin stain and Masson’s trichrome
staining. Substantial left ventricles remodeling in old age heart and secondhand smoke exposure. (A) Morphological features of the left ventricle
of hematoxylin-eosin stained. Morphometric samples are at x100 magnification (up-panel). Morphometric samples are at x400 magnification)
(down-panel). The arrow points to the papillary muscle. (B) Histological examination of LV fibrosis by Masson’s trichrome staining. Morphological
features of left ventricular hematoxylin-eosin stained. Morphometric samples are at x100 magnification (up-panel). Morphometric samples are at x400
magnification) (down-panel). The long arrow points to the papillary muscle, short arrow points to collagen. (C) western blotting for ANP and BNP
protein in MYC, MYS, MOC and MOS groups from the indicated left ventricular extracts. (D). Statistical analysis ANP and BNP protein expression levels
in MYC, MYS, MOC and MOS groups. Data are means ± SD. *P < 0.05, **P < 0.01 significantly statistical differences vs. MYC group (two-way ANOVA).
MYC; male young control, MYS; male young SHS exposure, MOC; male old control, MOS; male old SHS exposure.
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accumulation of LV fibrosis in the MYS, MOC and
MOS groups. Morphometric samples are at x100 mag-
nification (Figure 1B, up-panel) and x400 magnification
(Figure 1B, down-panel). This finding supported by
data Table 1 and Table 2 showing aging and SHS expos-
ure trended to LVH and fibrosis. The molecular mecha-
nisms of cardiac hypertrophy markers, ANP and BNP
protein expression were detected by western blotting
analysis. To determine whether left ventricular will be-
come hypertrophy Figure 1C shows that ANP and BNP
increased in MYS, MOC and MOS groups, when com-
pared with the MYC group. There was no significant
difference between aging and aging SHS exposure.
Molecular characterization of MEK1-ERK1/2-GATA4
signaling pathway in regulation of concentric left
ventricular hypertrophy
MEK1-ERK1/2-GATA4 signaling pathway regulates the
left ventricle balance between concentric and eccentric
growth [20]. To explore whether MEK1-ERK1/2-GATA4
signaling pathway activation induced concentric left
ventricular hypertrophy, inhibition of this pathway
resulted in eccentric hypertrophy in aging and aged
SHS exposure hamsters. The MEK1-ERK1/2-GATA4
signaling pathway regulates concentric cardiac hyper-
trophy. To determine the MEK1-ERK1/2-GATA4 sig-
naling pathway as a potential regulator of concentric
hypertrophy in MYS, MOC and MOS groups weexamined p-MEK1, MEK1, p-ERK1/2, ERK1/2 and
GATA4 protein expression levels using western blot-
ting analysis. As Figure 2 shows, MEK1 and its active
form of p-MEK1 were increased in the MYS group, but
decreased in the MOC and MOS groups (Figure 2A).
The results showed a two-way ANOVA statistical ana-
lysis and then student’s t-test used in the comparison
between MOC and MOS group. The ratio of p-MEK1
to MEK1 was increased in MYS group (p < 0.05), but
decreased in MOC (p < 0.05) and MOS groups (p <
0.01), when compared with MYC. However, significant
differences between the MOC and MOS groups (p <
0.05) were found. We found ERK1/2, p-ERK1/2, and
transcription factor, GATA4, have the same results
with MEK1 expression trend to MYS group increase,
but a trend toward reduction in the MOC and MOS
groups (Figure 2A). When compared with MOC
group, we found MOS group protein expression was
significantly lower than that for the MOC group. Pro-
tein expression levels were quantified using analysis of
variance (ANOVA) to assess all experimental groups.
GATA 4 relative density and ratio of p-ERK1/2 to
ERK1/2 were increased in MYS group (p < 0.05), and
in the MOC (p < 0.05) and MOS groups (p < 0.01) de-
creased, when compared with MYC group (Figure 2B).
When compared with aging, we found MOS group
was lower than MOC group (p < 0.05) (Figure 2B). The
results suggest only MYS group tended to LV concen-
tric hypertrophy.
Figure 3 Inflammatory cytokines, IL-6, TNFα, JAK1 and STAT3 mediated eccentric left ventricular hypertrophy in aging and aged SHS
exposure hamsters. (A). Western blot analysis of Inflammatory protein, IL-6 and TNFα, expression in MYC, MYS, MOC and MOS groups. (B).
Quantification of densitometry analysis of IL-6 and TNFα protein expression levels. Statistical analysis of IL-6 and TNFα protein expression levels in
MYC, MYS, MOC and MOS groups. All data are presented as means ± SD. *p < 0.05, **p < 0.01 significant statistical differences compared with male
young control (MYC). (C). Western blot and immunohistochemical analysis detection of SIRT1 in the four experimental groups were measured.
(D). Western blot analysis of cytokines, JAK1 and STAT3 protein expression in MYC, MYS, MOC and MOS groups. (E). Quantification of densitometry
analysis of JAK1 and STAT3 protein expression levels. All data are presented as means ± SD. *p < 0.05, **p < 0.01 significant statistical differences
compared with male young control (MYC).
Figure 2 MEK1-ERK1/2-GATA4 signaling pathway in male young exposure to SHS promotes left ventricular concentric hypertrophy.
(A). Western blot analysis of p-MEK1, MEK 1, p-ERK1/2, ERK1/2 and GATA4 protein expression in the MYC, MYS, MOC and MOS groups. (B).
Quantification of densitometry analysis of protein expression levels. Statistical analysis of the p-MEK1/MEK1 and p-ERK1/2/ERK1/2 ratios and GATA4
densitometry in MYC, MYS, MOC and MOS groups. All data are presented as means ± SD. *p < 0.05, **p < 0.01 significantly statistical differences
compared with male young control (MYC). *p < 0.05, **p < 0.01 significantly statistical differences compared with male old control (MOC).
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Figure 4 (See legend on next page.)
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Figure 4 Stimulation of calcineurin-NFAT, p-MEK5-MEK5, and p-ERK5-ERK5 activation promote eccentric left ventricular hypertrophy in
aging and aged SHS exposure. (A). Protein expression levels of calcineurin, NFAT, p-NFAT, p-MEK5, MEK5, p-ERK5 and ERK5 in the MYC, MYS,
MOC and MOS groups were measured by western blotting analysis. (B). Statistical analysis of calcineurin densitometry and NFAT/p-NFAT,
p-MEK5/MEK5, and p-ERK5/ERK5 ratios in MYC, MYS, MOC and MOS groups. All data are presented as means ± SD. *p < 0.05, **p < 0.01 significant
statistical differences compared with male young control (MYC).
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smoke (SHS) exposure with pathological age-related
diseases
Cytokines, TNF α, IL-6, JAK1 and STAT3 as markers of
inflammation response may play a major role in the risk
for cardiovascular disease, which is also recognized as
essential mediator of pathological aging. To determine
whether inflammatory processes are linked to the in-
volvement of inflammation in the SHS exposure-related
concentric LV hypertrophy transition to age-related eccen-
tric LV hypertrophy pathogenesis. According Figure 3A,C
and D, TNF α, IL-6, JAK1, STAT3 and SIRT1 protein
expression by western blotting analysis were increased in
MOC (p < 0.05) and MOS groups (p < 0.01), when com-
pared with the MYC group (Figure 3). Interestingly, statis-
tical analysis observed no significant difference in the
MYS group when compared with the MYC group. How-
ever, compared with the MOC group, the MOS group
showed no significant difference in changes compared
with the MOC group. According to immunohisto-
chemistry results showed SIRT 1 expression in the
MYC, MYS, MOC and MOS groups. We observed
SIRT 1 expression was as disclosed at immunohisto-
chemistry in MYC and MYS groups. However, old
group expression was weaker including aged SHS
exposure group (Figure 3C). Experimental evidences
inflammatory response leads aging tended toward
pathological age-related LV hypertrophy.
Calcineurin/NFAT-MEK5-ERK5 signaling pathway induced
aging related pathological left ventricular eccentric
hypertrophy
NFAT is the Ca2+_ dependent calcineurin which was
identified as an eccentric hypertrophic signaling mol-
ecule in the myocardium in pathological cardiac hyper-
trophy. We discuss recent findings related continued
activation of calcineurin/NFAT whether throughout the
aging included eccentric cardiac hypertrophy. Our data
showing calcineurin/NFAT protein expression increases
was to maintain the hypertrophy profile of the left ven-
tricle in the aging, but calcineurin/NFAT activation was
also increased in the aged SHS exposure (Figure 4A).
Interestingly, calcineurin and NFAT expression did not
found increased in MYS group, but could observe the p-
NFAT expression increased (Figure 4A). Quantitative
and statistic analysis results, we found calcineurinprotein expression was increased in MOC (p < 0.05)
and MOS (p < 0.01) groups, when compared with
MYC group. No significant difference between MYC
and MYS groups (Figure 4B). The NFAT/p-NFAT ratio
in the MOC and MOS groups were increased (p < 0.05
and p < 0.01, respectively), when compared with the
MYC group. ERK5 is activated by the upstream MEK
5 kinase in responses to LV eccentric hypertrophy.
From a two-way ANOVA analysis, we found the
p-MEK5/MEK and p-ERK5/ERK5 ratios in MOC (p <
0.05) and MOS (p < 0.01) groups were increased
compared with MYC group (Figure 4B). We suggest
that aging and aged SHS exposure trended toward ec-
centric LVH.
Conclusions
The left ventricular hypertrophy (LVH) phase during
adaptive stress and pressure overload is the major reason
individual myocytes grew into concentric or eccentric
LVH [21,22]. The aging effects on cardiovascular disease
are similar to SHS exposure [23,24]. To determine sec-
ondhand smoke (SHS) exposure transition to concentric
LVH to aging- induced eccentric, SHS exposure and
aging changed the left ventricular morphology and re-
duced heart function at systolic and diastolic (Tables 1,
2, and 3). We observed that left ventricular mass in-
creases and left ventricular wall thickness increased.
Given the above evidence which can be preliminary
determined as cardiac or left ventricular hypertrophy,
according to two-dimensional targeted M-mode echo-
cardiogram results, we suggest that SHS exposure and
aging lead to LV pathological hypertrophy. Recent
studies have advanced the notion that SHS exposure
would impair endothelial function, and which was a
time- and concentration-dependent main [25,26], in
fact, the aged SHS exposure-induced the coronary ar-
teries is easily developed cardiac valves and coronary
stenosis. Nevertheless, aging is a physiological re-
sponse which is an irreversible system in our life [27],
but in a bad environment such as alcohol, smoke and
SHS exposure, which will lead this physiological aging
transfer pathological aging. From H&E staining and
fetal genes expression, we observed cross-section of
pathological LV hypertrophy and fibrosis as well as
commonly associated with up regulation of ANP and
BNP protein expression by western blotting (Figure 1).
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the normal elderly who do not have heart disease. A
previous study demonstrated that the normal aging
process affects clinical heart disease in ways such as
hypertensives, implying more pronounced reductions
in cardiac and vascular compliance, because aortic
valve calcium and mitral valve annular calcium ap-
peared [28]. However, it is debatable whether the aged
SHS exposure resulted in LV pathological hypertrophy
which maybe occur eccentric. Goldenburg had clearly
demonstrated that it is this property of the hypertro-
phied heart which the muscle fibres are increased in
size, the nuclei are larger than normal, and there is
generally present a hyperplasia. In other words, the
expression of the overwork heart showed an absolute
and relative increase in the size of the heart, and the
relative weights of the heart and body. A left ventricu-
lar hypertrophy should place an predominant role re-
sulted from hypertension in the systemic circulation.
The fact, we justified bear out this assumption that
the principal factors in the production of cardiac
hypertrophy is an aortic insufficiency. Aortic insuffi-
ciency resulted in the blood backflow during cardiac
diastolic condition. Aging is considered as a major risk
factor cardiovascular diseases. We conclude SHS ex-
posure will be exacerbated age- related left ventricular
hypertrophy. Research further elucidating the under-
lying development of pathological mechanisms and
potential countermeasures. These explore knowledge
may influence therapeutic strategies for the treatment
of cardiovascular disease in old age [28,29]. Accumu-
lated all evidence indicate that MEK1-ERK1/2-GATA4
signaling pathway induced concentric LVH in youngFigure 5 The underlying of pathophysiological mechanisms related to
to concentric LV hypertrophy transfer to eccentric LV hypertrophy.SHS exposure, but not find aging and aged SHS expos-
ure, whereas calcineurin/NFAT-MEK5-ERK5 signaling
pathway activation-induced eccentric LVH was ob-
served. One possibility is that transcription factors
such as NFAT and GATA4 [30] are up-regulated in
response to calcium-independent pathway of hyper-
trophy. Altered intracellular calcium is beyond the
scope of the aging [31]. The other reason may be two
signaling pathways have crosstalk to each other. A fur-
ther possibility is SHS exposure-induced inflammation
response resulted in TNFα, IL-6, JAK1, STAT3 and
SIRT1 protein expression increases only in aging
hamsters (Figure 3). Low concentration and short-
term SHS exposure time only affected aging hamsters.
Therefore, we can make sure that inflammation oc-
curred in aging. On the other hand, MEK1-ERK1/2-
GATA4 signaling inhibited calcineurin/NFAT and
MEK5/ERK5 signals, and which attenuate eccentric
LVH response [32,33]. Indeed, MEK1/ERK1/2 [34],
MEK5/ERK5 [35], JAK1/STAT3 [36] and calcineurin/
NFAT [37] are cooperatively regulated hypertrophy
expression. Indeed, SHS exposure results in superim-
posed with aging effects. Only in aging has detrimental
consequences, one possibility is that low dose and
short time exposure to SHS could be explained [38,39].
SIRT1 expression can ascertain the aging degree and
suppressed inflammatory aging. The underlying of
pathophysiological mechanisms related to aging and
exposure to SHS are depicted in Figure 5. Based on the
presented evidences, it is concluded that transient
exposure to low dose SHS may cause significant adverse
effects on the aging human body presenting an acute
health hazard.aging exposure to SHS are depicted. Inflamm-aging changes lead
Wu et al. BMC Cardiovascular Disorders 2014, 14:195 Page 10 of 11
http://www.biomedcentral.com/1471-2261/14/195Competing interests
The authors declare that they have no competing interests.Authors’ contributions
JP drafted the manuscript and performed the main experiment. CH, TJ, WW,
YL, CC, CH, CH and CY participated in the design of this study and data
analysis. CH, TJ, and WW performed some parts of Western Blot. YL and CC
performed some parts of H&E staining, CH performed some parts of
Masson’s trichrome staining. TJ performed echocardiography analysis. CH
performed some parts of immunohistochemistry analysis. CH and CY
conceived the study, participated in this design and coordination and
helped draft the manuscript. All authors read and approved the final
manuscript.Acknowledgement
This work was supported by a grant from the National Science Council,
Republic of China (NSC 100-2314-B-039-018) and Taiwan Ministry of Health
and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-
B-212-113002). The authors declare that there are no conflicts of interest.
Author details
1Graduate Institute of Basic Medical Science, China Medical University,
Taichung, Taiwan. 2Department of Health and Nutrition Biotechnology, Asia
University, Taichung, Taiwan. 3School of Chinese Medicine, College of
Chinese Medicine, China Medical University Beigang Hospital, Taichung,
Taiwan. 4Chinese Medicine Department, China Medical University Beigang
Hospital, Beigang, Taiwan. 5Department of Biological Science and
Technology, China Medical University, Taichung, Taiwan. 6Department of
Pathology, Changhua Christian Hospital, Changhua, Taiwan. 7Department of
Medical Technology, Jen-Teh Junior College of Medicine, Nursing and
Management, Miaoli, Taiwan. 8Orthopedic Department, Armed Forces
General Hospital, Taichung, Taiwan. 9Department of Sports Sciences,
University of Taipei, Taipei, Taiwan. 10School of Chinese Medicine, China
Medical University, Taichung, Taiwan.
Received: 8 September 2014 Accepted: 11 December 2014
Published: 19 December 2014References
1. Hoegg UR: Cigarette smoke in closed spaces. Environ Health Perspect 1972,
2:117–128.
2. Tong EK, Glantz SA: Tobacco industry efforts undermining evidence
linking secondhand smoke with cardiovascular disease. Circulation 2007,
116:1845–1854.
3. Bard RL, Dvonch JT, Kaciroti N, Lustig SA, Brook RD: Is acute high-dose
secondhand smoke exposure always harmful to microvascular function
in healthy adults? Prev Cardiol 2010, 13:175–179.
4. Weeks SG, Glantz SA, De Marco T, Rosen AB, Fleischmann KE: Secondhand
smoke exposure and quality of life in patients with heart failure. Arch
Intern Med 2011, 171:1887–1893.
5. Slayton RL: Exposure to secondhand smoke may cause dental caries in
children. J Evid Based Dent Pract 2012, 12:8–9.
6. Heiss C, Amabile N, Lee AC, Real WM, Schick SF, Lao D: Brief secondhand
smoke exposure depresses endothelial progenitor cells activity and
endothelial function: sustained vascular injury and blunted nitric oxide
production. J Am Coll Cardiol 2008, 51:1760–1771.
7. Dai DF, Chen T, Johnson SC, Szeto H, Rabinovitch PS: Cardiac aging: from
molecular mechanisms to significance in human health and disease.
Antioxid Redox Signal 2012, 16:1492–1526.
8. Whittington HJ, Harding I, Stephenson CI, Bell R, Hausenloy DJ, Mocanu
MM, Yellon DM: Cardio protection in the aging, diabetic heart: the loss of
protective Akt signaling. Cardiovasc Res 2013, 99:694–704.
9. Waller BF: The old-age heart: normal aging changes which can produce
or mimic cardiac disease. Clin Cardiol 1988, 11:513–517.
10. Sugiura M: Characteristic features of the heart disease in the elderly.
Nihon Ronen Igakkai Zasshi 1994, 31:182–186.
11. Hacker TA, McKiernan SH, Douglas PS, Wanagat J, Aiken JM: Age-related
changes in cardiac structure and function in Fischer 344 x Brown
Norway hybrid rats. Am J Physiol Heart Circ Physiol 2006, 290:H304–H311.12. Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Myocyte death, growth,
and regeneration in cardiac hypertrophy and failure. Circ Res 2003,
92:139–150.
13. Juonala M, Magnussen CG, Venn A, Gall S, Kähönen M, Laitinen T: Parental
smoking in childhood and brachial artery flow-mediated dilatation in
young adults: the cardiovascular risk in young Finns study and the
childhood determinants of adult health study. Arterioscler Thromb Vasc
Biol 2012, 32:1024–1031.
14. Martin Rdos S, Martin LC, Franco RJ, Barretti P, Caramori JC, Castro JH:
Ventricular hypertrophy and cardiovascular mortality in hemodialysis
patients with low educational level. Arq Bras Cardiol 2012, 98:52–61.
15. van Eps CL, Jeffriess L, Haluska B, Hawley CM, Coombes J: Cardiac and
vascular structure and function parameters do not improve with
alternate nightly home hemodialysis: an interventional cohort study.
BMC Nephrol 2011, 12:51.
16. Olivetti G, Melissari M, Capasso JM, Anversa P: Cardiomyopathy of the
aging human heart. Myocyte loss and reactive cellular hypertrophy.
Circ Res 1991, 68:1560–1568.
17. Roffe C: Ageing of the heart. Br J Biomed Sci 1998, 55:136–148.
18. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM:
Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied
aging rat heart. Circ Res 1990, 67:871–885.
19. Kuo WW, Wu CH, Lee SD, Lin JA, Chu CY, Hwang JM: Second-hand smoke-
induced cardiac fibrosis is related to the Fas death receptor apoptotic
pathway without mitochondria-dependent pathway involvement in rats.
Environ Health Perspect 2005, 113:1349–1353.
20. Cittadini A, Grossman JD, Strömer H, Katz SE: Importance of an intact
growth hormone/insulin-like growth factor 1 axis for normal post-
infarction healing: studies in dwarf rats. Endocrinology 2001, 142:332–338.
21. Helms SA, Azhar G, Zuo C, Theus SA, Bartke A, Wei JY: Smaller cardiac cell
size and reduced extra-cellular collagen might be beneficial for hearts of
Ames dwarf mice. Int J Biol Sci 2010, 6:475–490.
22. Arai S, Machida A: Myocardial cell in left ventricular hypertrophy. Tohoku J
Exp Med 1972, 108:361–367.
23. Raya TE, Gaballa M, Anderson P, Goldman S: Left ventricular function and
remodeling after myocardial infarction in aging rats. Am J Physiol 1997,
273:H2652–H2658.
24. North BJ, Sinclair DA: The intersection between aging and cardiovascular
disease. Circ Res 2012, 110:1097–1108.
25. Schick SF, Glantz SA: Side stream cigarette smoke toxicity increases with
aging and exposure duration. Tob Control 2006, 15:424–429.
26. Priebe HJ: The aged cardiovascular risk patient. Br J Anaesth 2000,
85:763–778.
27. Barry SP, Davidson SM, Townsend PA: Molecular regulation of cardiac
hypertrophy. Int J Biochem Cell Biol 2008, 40:2023–2039.
28. Heineke J, Molkentin JD: Regulation of cardiac hypertrophy by
intracellular signaling pathways. Nat Rev Mol Cell Biol 2006, 7:589–600.
29. Molkentin JD: Calcineurin–NFAT signaling regulates the cardiac
hypertrophic response in coordination with the MAPKs. Cardiovasc Res
2004, 63:467–475.
30. Pikkarainen S, Tokola H, Kerkelä R, Ruskoaho H: GATA transcription factors
in the developing and adult heart. Cardiovasc Res 2004, 63:196–207.
31. Wilkins BJ, Dai Y-S, Bueno OF, Parsons SA, Jian X, Plank DM, Jones F,
Kimball TR, Molkentin JD: Calcineurin/NFAT coupling participates in
pathological, but not physiological. Cardiac Hypertrophy Circ Res 2004,
94:110–118.
32. Manukyan I, Galatioto J, Mascareno E, Bhaduri S, Siddiqui MA: Cross-talk
between calcineurin/NFAT and Jak/STAT signaling induces cardio
protective alphaB-crystallin gene expression in response to hypertrophic
stimuli. J Cell Mol Med 2010, 6B:1707–1716.
33. Sanna B, Bueno OF, Dai YS, Wilkins BJ, Molkentin JD: Direct and indirect
interactions between calcineurin-NFAT and MEK1-extracellular signal-
regulated kinase 1/2 signaling pathways regulate cardiac gene expres-
sion and cellular growth. Mol Cell Biol. 2005, 25:865–878.
34. Kimura TE, Jin J, Zi M, Prehar S, Liu W, Oceandy D, Abe J, Neyses L,
Weston AH, Cartwright EJ, Wang X: Targeted deletion of the
extracellular signal-regulated protein kinase 5 attenuates hypertrophic
response and promotes pressure overload –induced apoptosis in the heart.
Circ Res 2010, 106:961–970.
35. Kodama H, Fukuda K, Pan J, Sano M, Takahashi T, Kato T, Makino S, Manabe
T, Murata M, Ogawa S: Significance of ERK cascade compared with JAK/
Wu et al. BMC Cardiovascular Disorders 2014, 14:195 Page 11 of 11
http://www.biomedcentral.com/1471-2261/14/195STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. Am J
Physiol Heart Circ Physiol 2000, 279:H1635–H1644.
36. Oakley D: General cardiology: the athlete’s heart. Heart 2001, 86:722–726.
37. Jefferis BJ, Lawlor DA, Ebrahim S, Wannamethee SG, Feyerabend C, Doig M,
McMeekin L, Cook DG, Whincup PH: Cotinine-assessed second-hand
smoke exposure and risk of cardiovascular disease in older adults. Heart
2010, 96:854–859.
38. Frey PF, Ganz P, Hsue PY, Benowitz NL, Glantz SA, Balmes JR, Schick SF:
The exposure-dependent effects of aged secondhand smoke on
endothelial function. J Am Coll Cardiol 2012, 59:1908–1913.
39. Lakatta EG, Yin FC: Myocardial aging: functional alterations and related
cellular mechanisms. Am J Physiol 1982, 242:H927–H941.
doi:10.1186/1471-2261-14-195
Cite this article as: Wu et al.: Secondhand smoke exposure toxicity
accelerates age-related cardiac disease in old hamsters. BMC
Cardiovascular Disorders 2014 14:195.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
